Rhabdoid Tumor Predisposition Syndrome
Symptoms, Doctors, Treatments, Advances & More

Save information for later
Sign Up

Learn About Rhabdoid Tumor Predisposition Syndrome

What is the definition of Rhabdoid Tumor Predisposition Syndrome?
Limb-girdle muscular dystrophy type 2A (LGMD2A) is an autosomal recessive limb-girdle muscular dystrophy characterized by progressive, symmetrical weakness of the proximal limb and girdle muscles (mainly those around the hips and shoulders) without heart involvement or intellectual disability. The condition is caused by genetic changes in the CAPN3 gene. Type 2A is the most common form of limb-girdle muscular dystrophy, accounting for about 30 percent of cases. LGMD2A is also known as primary calpainopathy. Calpainopathies are diseases caused by genetic changes in the CAPN3 gene and can be autosomal recessive or autosomal dominant. Pelvifemoral limb-girdle muscular dystrophy (also known as Leyden-Mobius LGMD) is the most frequently observed subtype. In these cases, muscle weakness is first evident in the pelvic girdle and later in the shoulder girdle. In most cases, muscle weakness is first evident in the shoulder girdle and later in the pelvic girdle; HyperCKemia is usually observed in children or young individuals. In most cases, those affected do not have symptoms, just high levels of creatine kinase in their blood.
What are the alternative names for Rhabdoid Tumor Predisposition Syndrome?
  • Limb-girdle muscular dystrophy type 2A
  • Muscular dystrophy limb girdle type 2A, Erb type
  • Calpainopathy
  • LGMD2
  • LGMD2A
  • Leyden-Moebius muscular dystrophy
  • Limb-girdle muscular dystrophy type 2
  • Muscular dystrophy, pelvofemoral
Who are the top Rhabdoid Tumor Predisposition Syndrome Local Doctors?
Distinguished in Rhabdoid Tumor Predisposition Syndrome
Distinguished in Rhabdoid Tumor Predisposition Syndrome
Referral may be required

Rockefeller Outpatient Pavilion

160 E 53rd St, 
New York, NY 
Languages Spoken:
English
Accepting New Patients
Offers Telehealth

Mark Dickson is an Oncologist practicing medicine in New York, New York. Dr. Dickson is rated as a Distinguished provider by MediFind in the treatment of Rhabdoid Tumor Predisposition Syndrome. He is also highly rated in 28 other conditions, according to our data. His clinical expertise encompasses Adult Soft Tissue Sarcoma, Liposarcoma, Undifferentiated Pleomorphic Sarcoma, Synovial Sarcoma, and Endoscopy. Dr. Dickson is currently accepting new patients.

Distinguished in Rhabdoid Tumor Predisposition Syndrome
Distinguished in Rhabdoid Tumor Predisposition Syndrome
Referral may be required

Duke Cancer Center

20 Duke Medicine Cir, 
Durham, NC 
Languages Spoken:
English
Accepting New Patients
Offers Telehealth

Richard Riedel is an Oncologist practicing medicine in Durham, North Carolina. Dr. Riedel is rated as a Distinguished provider by MediFind in the treatment of Rhabdoid Tumor Predisposition Syndrome. He is also highly rated in 30 other conditions, according to our data. His clinical expertise encompasses Adult Soft Tissue Sarcoma, Liposarcoma, Desmoid Tumor, and Angiosarcoma. Dr. Riedel is board certified in American Board Of Internal Med, Internal Medicine and American Board Of Internal Med, Medical Oncology. Dr. Riedel is currently accepting new patients.

 
 
 
 
Learn about our expert tiers
Learn More
Distinguished in Rhabdoid Tumor Predisposition Syndrome
Distinguished in Rhabdoid Tumor Predisposition Syndrome
Referral may be required

Rockefeller Outpatient Pavilion

160 E 53rd St, 
New York, NY 
Languages Spoken:
English
Accepting New Patients
Offers Telehealth

Sandra D'angelo is an Oncologist practicing medicine in New York, New York. Dr. D'angelo is rated as a Distinguished provider by MediFind in the treatment of Rhabdoid Tumor Predisposition Syndrome. She is also highly rated in 33 other conditions, according to our data. Her clinical expertise encompasses Synovial Sarcoma, Adult Soft Tissue Sarcoma, Liposarcoma, Merkel Cell Carcinoma, and Liver Embolization. Dr. D'angelo is currently accepting new patients.

What are the latest Rhabdoid Tumor Predisposition Syndrome Clinical Trials?
Match to trials
Find the right clinical trials for you in under a minute
Get started
Who are the sources who wrote this article ?

Published Date: May 02, 2022
Published By: Genetic and Rare Diseases Informnation Center